My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Serum visfatin increases with progressive beta-cell deterioration.

    López-Bermejo A, Chico-Julià B, Fernàndez-Balsells M, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM.

    Diabetes. 2006 Oct;55(10):2871-5.PMID: 17003355 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.

    Sandeep S, Velmurugan K, Deepa R, Mohan V.

    Metabolism. 2007 Apr;56(4):565-70.PMID: 17379018 [PubMed - indexed for MEDLINE]Related articles

    3.

    Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.

    Fernández-Real JM, Moreno JM, Chico B, López-Bermejo A, Ricart W.

    Diabetes Care. 2007 Mar;30(3):616-21.PMID: 17327330 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.

    Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ.

    J Clin Endocrinol Metab. 2006 Jan;91(1):295-9. Epub 2005 Oct 18.PMID: 16234302 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

    Am J Kidney Dis. 2007 Feb;49(2):237-44.PMID: 17261426 [PubMed - indexed for MEDLINE]Related articles

    6.

    Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.

    Retnakaran R, Youn BS, Liu Y, Hanley AJ, Lee NS, Park JW, Song ES, Vu V, Kim W, Tungtrongchitr R, Havel PJ, Swarbrick MM, Shaw C, Sweeney G.

    Clin Endocrinol (Oxf). 2008 Dec;69(6):885-93. Epub 2008 Apr 10.PMID: 18410550 [PubMed - indexed for MEDLINE]Related articles

    7.

    Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

    Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K.

    Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):544-8.PMID: 17177135 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes.

    Zhu J, Schott M, Liu R, Liu C, Shen B, Wang Q, Mao X, Xu K, Wu X, Schinner S, Papewalis C, Scherbaum WA, Liu C.

    Horm Metab Res. 2008 Nov;40(11):801-5. Epub 2008 Aug 6.PMID: 18686225 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.

    Pfützner A, Marx N, Walcher D, Löbig M, Seidel D, Forst T.

    Clin Lab. 2008;54(7-8):237-41.PMID: 18942491 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma visfatin concentrations in subjects with type 1 diabetes mellitus.

    Toruner F, Altinova AE, Bukan N, Arslan E, Akbay E, Ersoy R, Arslan M.

    Horm Res. 2009;72(1):33-7. Epub 2009 Jun 30.PMID: 19571557 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).

    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.

    Diabetes. 2006 Aug;55(8):2333-9.PMID: 16873698 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.

    Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, Han JF, Zhao Y, Li G, Luo M.

    Diabet Med. 2006 Sep;23(9):967-73.PMID: 16922702 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

    Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T.

    Metabolism. 2007 Apr;56(4):451-8.PMID: 17378999 [PubMed - indexed for MEDLINE]Related articles

    14.

    Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.

    Marcinkowska M, Lewandowski KC, Lewiński A, Bieńkiewicz M, Basińska-Lewandowska M, Salata I, Randeva HS.

    Endokrynol Pol. 2007 May-Jun;58(3):188-94.PMID: 17940983 [PubMed - indexed for MEDLINE]Related articles

    15.

    Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

    Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, Ozgurtas T, Bingol S.

    Diabetes Res Clin Pract. 2007 Apr;76(1):24-9. Epub 2006 Sep 7.PMID: 16956691 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.

    Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, Mari A, Heine RJ, Diamant M.

    Diabetes Care. 2007 Nov;30(11):2916-21. Epub 2007 Jul 31. Erratum in: Diabetes Care. 2008 Apr;31(4):835. PMID: 17666465 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.

    Lewandowski KC, Stojanovic N, Press M, Tuck SM, Szosland K, Bienkiewicz M, Vatish M, Lewinski A, Prelevic GM, Randeva HS.

    Diabetologia. 2007 May;50(5):1033-7. Epub 2007 Mar 2.PMID: 17334748 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased visfatin concentrations in women with gestational diabetes mellitus.

    Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G.

    Clin Sci (Lond). 2006 May;110(5):605-9.PMID: 16489932 [PubMed - indexed for MEDLINE]Related articles

    19.

    Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes.

    Haider DG, Pleiner J, Francesconi M, Wiesinger GF, Müller M, Wolzt M.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4702-4. Epub 2006 Aug 8.PMID: 16895956 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.

    Alghasham AA, Barakat YA.

    Saudi Med J. 2008 Feb;29(2):185-92.PMID: 18246224 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity